TIS Share Price

Open 0.04 Change Price %
High 0.04 1 Day 0.00 0.00
Low 0.04 1 Week 0.00 0.00
Close 0.04 1 Month 0.00 0.00
Volume 2119254 1 Year 0.00 0.00
52 Week High 0.05
52 Week Low 0.04
TIS Important Levels
Resistance 2 0.04
Resistance 1 0.04
Pivot 0.04
Support 1 0.04
Support 2 0.04
ASX Australia Most Active Stocks
AGO 0.02 0.00%
AGO 0.02 0.00%
AGO 0.02 0.00%
AKK 0.01 0.00%
TON 0.09 -10.00%
TON 0.09 -10.00%
TON 0.09 -10.00%
FAR 0.07 0.00%
FAR 0.07 0.00%
FAR 0.07 0.00%
More..
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
PMQ 0.03 50.00%
OMH 0.18 28.57%
SRZ 0.05 25.00%
SRZ 0.05 25.00%
HGO 0.05 25.00%
HGO 0.05 25.00%
More..
ASX Australia Top Losers Stocks
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
RXL 0.01 -50.00%
RXL 0.01 -50.00%
RXL 0.01 -50.00%
GBA 0.02 -33.33%
DAU 0.02 -33.33%
More..

Tissue Therapies Ltd (ASX: TIS)

TIS Technical Analysis 5
As on 4th May 2016 TIS Share Price closed @ 0.04 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.05 & Strong Sell for SHORT-TERM with Stoploss of 0.04 we also expect STOCK to react on Following IMPORTANT LEVELS.
TIS Target for December
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
TIS Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.tissuetherapies.com
TIS Address
TIS
179 Turbot Street
Level 19
Brisbane, QLD 4000
Australia
Phone: 61 7 3334 3900
Fax: 61 7 3334 3999
Interactive Technical Analysis Chart Tissue Therapies Ltd ( TIS ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Tissue Therapies Ltd
TIS Business Profile
Tissue Therapies Limited, a biomedical technology company, researches, develops, and commercializes biomedical technologies for chronic wound healing and tissue regeneration worldwide. The company commercializes VitroGro ECM, a biomimetic scaffold comprising a synthetic extracellular matrix protein that replaces the degraded matrix of a hard to heal wounds for the patients and the healthcare providers. It develops treatments for acute and chronic wound healing applications, including chronic skin ulcers and burns, as well as treatments for psoriasis, scar prevention, and various cancers, such as breast, colon, and prostate. The company is headquartered in Brisbane, Australia.